RE:RE:RE:RE:Last week of Q3!GoldenDilemma wrote: Perspective is better in hindsight.
Since merger announcement things have been quite anticlimatic. Especially for POZN.
My PT for TRX is $4. What that'll convert to with Aralez conversion... we shall see. In any case, I can't do anything but hold because I see the long term potential.
But had I seen this coming I'd have sold at $2+ and rebought down here. TRX is close to 200MA and I wouldn't be surprised if $1.15 - $1.20 is in the cards until positive catalyst.
I think they're saving the positive catalyst until after the merger. Like it was pointed out there has been good news just no news releases. If Yosprala is already improved then wow.